Opitz, Christiane A. http://orcid.org/0000-0001-5575-9821
Somarribas Patterson, Luis F.
Mohapatra, Soumya R.
Dewi, Dyah L.
Sadik, Ahmed
Platten, Michael
Trump, Saskia
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (No 754688, No 643638, No 754688)
Bundesministerium für Bildung und Forschung (01ZX1402, 01ZX1402)
University of Costa Rica | Vicerrectoría de Investigación, Universidad de Costa Rica
Costa Rica’s Ministry of Science, Technology and Telecommunications
Article History
Received: 7 February 2019
Revised: 31 October 2019
Accepted: 6 November 2019
First Online: 10 December 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The data from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Project is publicly available.
: C.A.O. and M.P. are listed as inventors on the patents “Means and methods for treating and/or preventing natural AHR ligand-dependent cancer” and “Isotopic method for measurement of tryptophan and metabolites thereof”. M.P. is listed on the patent “Treatment of Kynurenine-producing tumors with AHR antagonists”. M.P. has received research support and consulting honoraria from Bayer. The other authors have declared that no competing interests exist.
: This work was supported by grants from the BMBF e:Med initiative (GlioPATH, 01ZX1402) to S.T. and C.A.O. C.A.O. and A.S. were supported by funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 754688. L.F.S.P. was supported by scholarships from the University of Costa Rica (UCR) and Costa Rica’s Ministry of Science, Technology and Telecommunications (MICITT).